Search
for
Sort by
Research 91–120 of 1000+
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Definition criteria and diagnostic assessments
- Polycystic ovary syndrome: Challenges in adolescence
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Dermatologic manifestations of endocrine disorders
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- The eye and the skin in endocrine metabolic diseases
- Male-pattern baldness and incident coronary heart disease and risk factors in the Heinz Nixdorf Recall Study
- High prevalence of poly cystic ovary syndrome among young Saudi medical students: an observational cross-sectional study
- Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- The skin landscape in diabetes mellitus. Focus on dermocosmetic management
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Diabetes mellitus and necrotizing fasciitis – a deadly combination; case report
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- Engineered Hair Follicle Mesenchymal Stem Cells Overexpressing Controlled-Release Insulin Reverse Hyperglycemia in Mice with Type l Diabetes
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Syndromes of Severe Insulin Resistance (SSIRs)
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- Insulin Resistance and Polycystic Ovary Syndrome
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?